Vanguard Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
4,026,800
+151,255
| +4% | +$774K | ﹤0.01% | 2541 |
|
|
2025
Q1 | $5.31M | Sell |
3,875,545
-109,680
| -3% | -$150K | ﹤0.01% | 3147 |
|
|
2024
Q4 | $12.3M | Buy |
3,985,225
+339,922
| +9% | +$1.05M | ﹤0.01% | 2837 |
|
|
2024
Q3 | $28.1M | Buy |
3,645,303
+350,731
| +11% | +$2.7M | ﹤0.01% | 2426 |
|
|
2024
Q2 | $28.3M | Buy |
3,294,572
+213,687
| +7% | +$1.83M | ﹤0.01% | 2394 |
|
|
2024
Q1 | $24.5M | Buy |
3,080,885
+101,673
| +3% | +$807K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $29.5M | Buy |
2,979,212
+39,369
| +1% | +$390K | ﹤0.01% | 2421 |
|
|
2023
Q3 | $33.1M | Buy |
2,939,843
+197,624
| +7% | +$2.23M | ﹤0.01% | 2330 |
|
|
2023
Q2 | $9.1M | Sell |
2,742,219
-7,703
| -0.3% | -$25.6K | ﹤0.01% | 2998 |
|
|
2023
Q1 | $10.9M | Buy |
2,749,922
+35,110
| +1% | +$139K | ﹤0.01% | 2888 |
|
|
2022
Q4 | $19.7M | Buy |
2,714,812
+111,068
| +4% | +$805K | ﹤0.01% | 2635 |
|
|
2022
Q3 | $9.43M | Sell |
2,603,744
-408,174
| -14% | -$1.48M | ﹤0.01% | 2977 |
|
|
2022
Q2 | $13.6M | Buy |
3,011,918
+297,955
| +11% | +$1.35M | ﹤0.01% | 2828 |
|
|
2022
Q1 | $20.6M | Buy |
2,713,963
+1,267,198
| +88% | +$9.6M | ﹤0.01% | 2757 |
|
|
2021
Q4 | $15.8M | Buy |
1,446,765
+61,939
| +4% | +$678K | ﹤0.01% | 2962 |
|
|
2021
Q3 | $17.9M | Buy |
+1,384,826
| New | +$17.9M | ﹤0.01% | 2924 |
|